glp-1 기전 중요) glp 1 (인테그란) 프로젠, 비만·당뇨 신약 'PG-102' 개발
Description
Important safety considerations include: Separate fiber supplements from medications : Take fiber supplements at least 2 hours apart from oral medications to avoid potential interference with absorption Monitor for obstruction symptoms : Severe abdominal pain, inability to pass gas, or vomiting requires immediate medical evaluation, as FDA labels for GLP-1 medications include rare postmarketing reports of intestinal obstruction (ileus) [1] [2] Coordinate with healthcare providers : Patients with inflammatory bowel disease, diverticulitis history, or other gastrointestinal conditions need individualized fiber recommendations Adjust fluid intake appropriately : Follow medical guidance if you have conditions requiring fluid restriction Patients should contact their healthcare provider if gastrointestinal symptoms persist despite dietary modifications, worsen significantly, or include warning signs such as blood in stool, unintentional weight loss beyond expected therapeutic effects, or severe abdominal pain

GLP-1 signaling has been shown to suppress ghrelin, a hunger promoting hormone that stimulates orexin producing neurons in the lateral hypothalamus [5]

The original GLP-1 receptor agonist was exenatide, which was first synthesised in 1996
That has changed with the generic release of liraglutide in summer 2024, and in this article, Ill look at when and how to use it
His research demonstrated that GLP-1 is produced in the intestinal L-cells and plays a crucial role in regulating blood sugar levels by enhancing insulin secretion and inhibiting glucagon release
Effect of dipeptidyl peptidase-4 inhibitors on bone metabolism and the possible underlying mechanisms